Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2022

Apr 6, 2022

32853_dirs_2022-04-06_13ea5631-f9d9-4a10-b3f8-1ebe4b3e922c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2022-04-04

Reporting Person: Casdin Partners Master Fund, L.P. (Director)
Reporting Person: Casdin Capital, LLC (Director, 10% Owner)
Reporting Person: Casdin Partners GP, LLC (Director, 10% Owner)
Reporting Person: Casdin Private Growth Equity Fund II, L.P. (Director, 10% Owner)
Reporting Person: Casdin Private Growth Equity Fund II GP, LLC (Director, 10% Owner)